Skip to main content
. 2023 Jan 6;11:e14622. doi: 10.7717/peerj.14622

Figure 8. The model in chemotherapy.

Figure 8

Relationships between risk scores and chemotherapeutic sensitivity. IC50s of sorafenib (A), gemcitabine (C), 5-fluorouracil (E), paclitaxel (G), and lapatinib (I) in the low- and high-risk groups. The relationship between the risk score and sensitivity to sorafenib (B), gemcitabine (D), 5-fluorouracil (F), paclitaxel (H), and lapatinib (J). IC50: half-maximal inhibitory concentration.